BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $175 | -43.4% | 3,500 | -28.6% | 0.00% | 0.0% |
Q2 2023 | $309 | +5.1% | 4,900 | -25.8% | 0.00% | – |
Q1 2023 | $294 | +254.2% | 6,600 | +247.4% | 0.00% | – |
Q4 2022 | $83 | -100.0% | 1,900 | -67.8% | 0.00% | -100.0% |
Q3 2022 | $388,000 | +92.1% | 5,900 | +47.5% | 0.00% | +100.0% |
Q2 2022 | $202,000 | -54.1% | 4,000 | -42.0% | 0.00% | -50.0% |
Q1 2022 | $440,000 | -40.5% | 6,900 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $739,000 | -5.4% | 6,900 | -9.2% | 0.00% | 0.0% |
Q3 2021 | $781,000 | +5.8% | 7,600 | -9.5% | 0.00% | 0.0% |
Q2 2021 | $738,000 | 0.0% | 8,400 | +10.5% | 0.00% | 0.0% |
Q1 2021 | $738,000 | -55.5% | 7,600 | -48.6% | 0.00% | -50.0% |
Q4 2020 | $1,659,000 | +148.7% | 14,800 | +105.6% | 0.01% | +100.0% |
Q3 2020 | $667,000 | +4.4% | 7,200 | -12.2% | 0.00% | 0.0% |
Q2 2020 | $639,000 | +43.9% | 8,200 | +7.9% | 0.00% | +50.0% |
Q1 2020 | $444,000 | -0.9% | 7,600 | +35.7% | 0.00% | 0.0% |
Q4 2019 | $448,000 | -58.7% | 5,600 | -62.2% | 0.00% | 0.0% |
Q3 2019 | $1,086,000 | +55.6% | 14,800 | +100.0% | 0.00% | -33.3% |
Q2 2019 | $698,000 | +89.7% | 7,400 | +60.9% | 0.00% | +50.0% |
Q1 2019 | $368,000 | +120.4% | 4,600 | +48.4% | 0.00% | +100.0% |
Q4 2018 | $167,000 | -37.0% | 3,100 | -8.8% | 0.00% | 0.0% |
Q3 2018 | $265,000 | -35.7% | 3,400 | -47.7% | 0.00% | -50.0% |
Q2 2018 | $412,000 | -23.8% | 6,500 | +10.2% | 0.00% | 0.0% |
Q1 2018 | $541,000 | +84.0% | 5,900 | +51.3% | 0.00% | +100.0% |
Q4 2017 | $294,000 | +83.8% | 3,900 | +69.6% | 0.00% | 0.0% |
Q3 2017 | $160,000 | -86.2% | 2,300 | -90.0% | 0.00% | -80.0% |
Q2 2017 | $1,160,000 | +43.0% | 22,900 | +12.8% | 0.01% | +25.0% |
Q1 2017 | $811,000 | +4.5% | 20,300 | -26.7% | 0.00% | +33.3% |
Q4 2016 | $776,000 | -0.3% | 27,700 | +5.7% | 0.00% | 0.0% |
Q3 2016 | $778,000 | – | 26,200 | – | 0.00% | – |
Q3 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2015 | $79,000 | – | 3,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |